The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 25th 2025
New research reveals how high blood sugar from type 2 diabetes alters brain function, mimicking early Alzheimer symptoms and impacting memory.
NACDS Comments on Health-Innovation Focus in State of the Union, Congressional Initiative
January 21st 2015In response to the announcement of a new healthcare program in the State of the Union address last night, and in recognition of ongoing Congressional initiatives related to healthcare innovation, National Association of Chain Drug Stores President and CEO Steven C. Anderson, IOM, CAE issued this statement.
Read More
FDA Approves Non-Opioid Injectable Painkiller
January 21st 2015Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.
Read More
Opioids for Chronic Pain: More Harm Than Help
January 20th 2015With Americans' use of opioids increasing, a panel from the National Institutes of Health set out to measure the drugs' effectiveness in treating long-term chronic pain, and its report suggested that the risks outweigh the benefits.
Read More
Walgreens Flu Indexâ„¢ for Week of Jan. 19, 2015
January 20th 2015The Walgreens Flu Indexâ„¢ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that's as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.
Read More
Pharmacy Quality Alliance and AJPB Forge New Partnership in 2015
January 20th 2015The Pharmacy Quality Alliance and The American Journal of Pharmacy Benefits (AJPB) are pleased to announce a partnership in which PQA will contribute a new column to each AJPB issue entitled, Medication Quality Matters.
Read More
Schizophrenia Drug Shows Promise in Late-Stage Trial
January 20th 2015Gedeon Richter and Actavis today announced positive results from a phase 3 trial evaluating the efficacy and safety of cariprazine, an investigational atypical antipsychotic, in preventing relapse among schizophrenia patients.
Read More